Willis Johnson & Associates’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-22,769
Closed -$3.88M 180
2025
Q1
$3.88M Sell
22,769
-155
-0.7% -$26K 0.29% 40
2024
Q4
$3.84M Sell
22,924
-931
-4% -$159K 0.3% 40
2024
Q3
$4.13M Buy
23,855
+150
+0.6% +$25.5K 0.31% 38
2024
Q2
$3.91M Buy
23,705
+132
+0.6% +$21.6K 0.32% 38
2024
Q1
$3.82M Buy
23,573
+89
+0.4% +$14K 0.33% 37
2023
Q4
$3.44M Buy
23,484
+50
+0.2% +$7.41K 0.31% 38
2023
Q3
$3.42M Sell
23,434
-155
-0.7% -$23.7K 0.35% 37
2023
Q2
$3.58M Buy
23,589
+363
+2% +$54.7K 0.38% 35
2023
Q1
$3.45M Buy
23,226
+120
+0.5% +$17.2K 0.41% 35
2022
Q4
$3.5M Buy
23,106
+357
+2% +$50K 0.46% 35
2022
Q3
$2.87M Buy
22,749
+152
+0.7% +$21.6K 0.42% 36
2022
Q2
$3.25M Buy
22,597
+263
+1% +$39.5K 0.45% 34
2022
Q1
$3.41M Sell
22,334
-2,715
-11% -$425K 0.45% 32
2021
Q4
$4.1M Buy
25,049
+18
+0.1% +$2.67K 0.53% 31
2021
Q3
$3.5M Buy
25,031
+1
+0% +$142 0.49% 32
2021
Q2
$3.38M Sell
25,030
-174
-0.7% -$23.5K 0.48% 30
2021
Q1
$3.41M Buy
+25,204
New +$3.29M 0.52% 29

Other funds holding PG

Willis Johnson & Associates's PG Position: Q2 2025 in Review

Willis Johnson & Associates sold out of Procter & Gamble (PG) in Q2 2025, closing a stake of 22,769 shares — an estimated $3.88M sold.

Willis Johnson & Associates first reported a position in PG in Q1 2021 and held it in 17 quarters. The position peaked at $4.13M in Q3 2024. 3,953 funds tracked by Wall St. Rank hold PG as of Q2 2025.

  • Willis Johnson & Associates reported no remaining Procter & Gamble position as of Q2 2025 after selling out during the quarter.
  • Willis Johnson & Associates sold 22,769 Procter & Gamble shares in Q2 2025, an estimated $3.88M.
  • Willis Johnson & Associates first reported a position in Procter & Gamble in Q1 2021 and held it in 17 quarters.
  • Willis Johnson & Associates's Procter & Gamble position peaked at $4.13M in Q3 2024.
  • 3,953 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2025.

Based on Willis Johnson & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.